Bolt Biotherapeutics Inc (BOLT)
$0.75
+0.01
(+1.9%)▲
Performance
- $0.73$0.76$0.75
2.03%
Downside
Day's Volatility :3.05%
Upside
1.04%
- $0.71$1.56$0.75
5.33%
Downside
52 Weeks Volatility :54.49%
Upside
51.92%
Returns
| Period | Bolt Biotherapeutics Inc | Sector (Health Care) | Index (Russel 2000) |
|---|---|---|---|
3 Months | -33.69% | 6.5% | 0.0% |
6 Months | -31.21% | 7.1% | 0.0% |
1 Year | -45.07% | 9.8% | 0.0% |
3 Years | -93.88% | 14.2% | -20.2% |
Highlights
Market Capitalization | 27.8M |
Book Value | $2.73 |
Earnings Per Share (EPS) | -1.66 |
Wall Street Target Price | 1.25 |
Profit Margin | 0.0% |
Operating Margin TTM | -324.08% |
Return On Assets TTM | -26.81% |
Return On Equity TTM | -48.14% |
Revenue TTM | 11.3M |
Revenue Per Share TTM | 0.3 |
Quarterly Revenue Growth YOY | 188.79999999999998% |
Gross Profit TTM | 1.6M |
EBITDA | -73.0M |
Diluted Eps TTM | -1.66 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | -1.34 |
EPS Estimate Next Year | -1.07 |
EPS Estimate Current Quarter | -0.51 |
EPS Estimate Next Quarter | -0.48 |
Analyst Recommendation
- Current
- 1M Ago
- 3M Ago
Analyst Forecast
What analysts predicted
Upside of 66.67%
Technicals Summary
Sell
Neutral
Buy
Bolt Biotherapeutics Inc is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
 Bolt Biotherapeutics Inc | 0.79% | -31.21% | -45.07% | -93.88% | -97.71% |
 Moderna, Inc. | -1.67% | 18.26% | -0.21% | -64.15% | 752.69% |
 Regeneron Pharmaceuticals, Inc. | -0.46% | 13.21% | 45.59% | 84.19% | 244.2% |
 Novo Nordisk A/s | -11.0% | 18.31% | 61.56% | 186.46% | 423.59% |
 Vertex Pharmaceuticals Incorporated | 3.85% | 14.43% | 39.88% | 147.45% | 195.07% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
Bolt Biotherapeutics Inc | NA | NA | NA | -1.34 | -0.48 | -0.27 | NA | 2.73 |
Moderna, Inc. | 24.73 | NA | 0.0 | -7.19 | -0.38 | -0.16 | NA | 33.47 |
Regeneron Pharmaceuticals, Inc. | 31.35 | 31.35 | 1.46 | 44.44 | 0.15 | 0.08 | NA | 250.15 |
Novo Nordisk A/s | 44.28 | 44.28 | 2.36 | 3.43 | 1.0 | 0.25 | 0.01 | 22.18 |
Vertex Pharmaceuticals Incorporated | 31.85 | 31.85 | 0.53 | 16.98 | 0.24 | 0.13 | NA | 71.8 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
Bolt Biotherapeutics Inc | Buy | $27.8M | -97.71% | NA | 0.0% |
Moderna, Inc. | Buy | $45.3B | 752.69% | 24.73 | -115.82% |
Regeneron Pharmaceuticals, Inc. | Buy | $116.9B | 244.2% | 31.35 | 29.45% |
Novo Nordisk A/s | Buy | $572.0B | 423.59% | 44.28 | 36.55% |
Vertex Pharmaceuticals Incorporated | Buy | $126.7B | 195.07% | 31.85 | 39.46% |
Insights on Bolt Biotherapeutics Inc
Increasing Revenue
Revenue is up for the last 2 quarters, 2.08M → 5.27M (in $), with an average increase of 60.4% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -17.90M → -10.81M (in $), with an average increase of 65.6% per quarter
Vs NVO
In the last 1 year, Novo Nordisk A/s has given 61.6% return, outperforming this stock by 106.7%
Vs NVO
In the last 3 years, Novo Nordisk A/s has given 186.5% return, outperforming this stock by 280.4%
Institutional Holdings
Vivo Capital, LLC
9.24%TANG CAPITAL MANAGEMENT LLC
8.97%Sofinnova Ventures
7.22%Pivotal bioVenture Partners Investment Advisor LLC
4.96%Newtyn Management LLC
4.46%Orbimed Advisors, LLC
4.04%
Company Information
bolt biotherapeutics is a start-up with compelling technology from dr. engleman’s lab at stanford university, which demonstrated complete cures in numerous cancer models. the company is backed by strong life sciences investors and is early in its growth curve, seeking bright, highly motivated individuals that will be the company’s future leaders to help it further develop and bring to patients novel and curative biotherapies.
Organization | Bolt Biotherapeutics Inc |
Employees | 100 |
CEO | Dr. Randall C. Schatzman Ph.D. |
Industry | Healthcare |
